|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4962091A
(en)
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
US7070994B2
(en)
|
1988-03-21 |
2006-07-04 |
Oxford Biomedica (Uk) Ltd. |
Packaging cells
|
|
WO1990002806A1
(en)
|
1988-09-01 |
1990-03-22 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5817491A
(en)
|
1990-09-21 |
1998-10-06 |
The Regents Of The University Of California |
VSV G pseusdotyped retroviral vectors
|
|
DE69233013T2
(de)
|
1991-08-20 |
2004-03-04 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
WO1994007529A1
(en)
|
1992-09-25 |
1994-04-14 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
EP1024198A3
(en)
|
1992-12-03 |
2002-05-29 |
Genzyme Corporation |
Pseudo-adenoviral vectors for the gene therapy of haemophiliae
|
|
US5834256A
(en)
|
1993-06-11 |
1998-11-10 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
|
EP0705344B8
(en)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Adenovirus vectors for gene therapy
|
|
AU687117B2
(en)
|
1993-10-25 |
1998-02-19 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
|
PT728214E
(pt)
|
1993-11-09 |
2004-11-30 |
Ohio Med College |
Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
FR2751345B1
(fr)
|
1996-07-16 |
1998-09-18 |
Univ Paris Curie |
Lignees d'encapsidation hautement productrices
|
|
WO1998011244A2
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US6306434B1
(en)
|
1997-02-12 |
2001-10-23 |
Chong Kun Dang Corp. |
Pharmaceutical composition comprising cyclosporin solid-state microemulsion
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
WO1999061601A2
(en)
|
1998-05-28 |
1999-12-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav5 vector and uses thereof
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
ATE362542T1
(de)
|
1998-11-05 |
2007-06-15 |
Univ Pennsylvania |
Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US6995009B1
(en)
|
1999-06-01 |
2006-02-07 |
Chugai Seiyaku Kabushiki Kaisha |
Packaging cell
|
|
CA2379166C
(en)
|
1999-08-09 |
2013-03-26 |
Targeted Genetics Corporation |
Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
|
|
US7056502B2
(en)
|
2000-04-28 |
2006-06-06 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids
|
|
ATE318923T1
(de)
|
2000-06-01 |
2006-03-15 |
Univ North Carolina |
Doppelsträngige parvovirus-vektoren
|
|
AU2001289852A1
(en)
|
2000-08-31 |
2002-03-13 |
Edwin Lundgren |
Control device for a steering kite on a boat
|
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
WO2002098432A1
(en)
|
2001-06-01 |
2002-12-12 |
The Brigham And Women's Hospital, Inc. |
Methods of treating cardiac disorders
|
|
WO2003042361A2
(en)
|
2001-11-09 |
2003-05-22 |
Government Of The United States Of America, Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
MX359371B
(es)
*
|
2001-11-13 |
2018-09-25 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
DK2573170T3
(en)
|
2001-12-17 |
2018-04-09 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 9, vectors containing them, and their use
|
|
PT1453547T
(pt)
|
2001-12-17 |
2016-12-28 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
|
US7091029B2
(en)
|
2002-09-23 |
2006-08-15 |
Applied Genetics Technologies Corporation |
High titer recombinant AAV production
|
|
US7485291B2
(en)
|
2003-06-03 |
2009-02-03 |
Cell Genesys, Inc. |
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
|
|
SI1633772T1
(sl)
|
2003-06-19 |
2016-06-30 |
Genzyme Corporation |
AAV virioni z zmanjšano imunoreaktivnostjo in uporaba za ta namen
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
EP2345731B1
(en)
|
2003-09-30 |
2015-10-21 |
The Trustees of the University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
US7960100B1
(en)
|
2004-04-30 |
2011-06-14 |
Celera Corporation |
Colon cancer targets and uses thereof
|
|
FR2872170B1
(fr)
|
2004-06-25 |
2006-11-10 |
Centre Nat Rech Scient Cnrse |
Lentivirus non interactif et non replicatif, preparation et utilisations
|
|
ES2525067T3
(es)
|
2005-04-07 |
2014-12-17 |
The Trustees Of The University Of Pennsylvania |
Método de incremento de la función de un vector de AAV
|
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
JP2009519710A
(ja)
|
2005-12-16 |
2009-05-21 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
遺伝子発現調節エレメントのハイスループットでの特徴付けのための機能性アレイ
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
|
WO2008024998A2
(en)
|
2006-08-24 |
2008-02-28 |
Virovek, Inc. |
Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
|
|
JP2011512156A
(ja)
|
2008-02-19 |
2011-04-21 |
アムステルダム モレキュラー セラピューティクス ビー．ブイ． |
昆虫細胞におけるパルボウイルスｒｅｐ及びｃａｐタンパク質の発現の最適化
|
|
WO2009126894A2
(en)
|
2008-04-11 |
2009-10-15 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for the diagnosis and treatment of angiogenic disorders
|
|
WO2010114948A2
(en)
|
2009-04-02 |
2010-10-07 |
University Of Florida Research Foundation, Inc. |
An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors
|
|
HRP20250897T1
(hr)
|
2009-05-02 |
2025-09-26 |
Genzyme Corporation |
Genska terapija za neurodegenerativne poremećaje
|
|
US8586526B2
(en)
|
2010-05-17 |
2013-11-19 |
Sangamo Biosciences, Inc. |
DNA-binding proteins and uses thereof
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
EP2524037B1
(en)
|
2010-01-12 |
2018-05-16 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
JP5988961B2
(ja)
|
2010-04-28 |
2016-09-07 |
ザ ジェイ． デヴィッド グラッドストーン インスティテューツ |
心筋細胞を発生させるための方法
|
|
CN105755044A
(zh)
|
2011-04-22 |
2016-07-13 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
US9828585B2
(en)
|
2011-08-30 |
2017-11-28 |
The J. David Gladstone Instututes |
Methods for generating cardiomyocytes
|
|
CA2853482C
(en)
|
2011-10-28 |
2020-05-19 |
Joshua Grieger |
Cell line for production of adeno-associated virus
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
EP2970972B1
(en)
|
2013-03-11 |
2018-08-15 |
Fondazione Telethon |
Mir-204 and mir-211 and uses thereof
|
|
WO2014143932A1
(en)
|
2013-03-15 |
2014-09-18 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
ES2926774T3
(es)
*
|
2013-03-15 |
2022-10-28 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para vectores AAV de doble unión de glicano
|
|
EP2994531B1
(en)
|
2013-05-10 |
2018-03-28 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
WO2015031686A1
(en)
|
2013-08-30 |
2015-03-05 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
|
EP3043822A1
(en)
|
2013-09-11 |
2016-07-20 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Compositions for preparing cardiomyocytes
|
|
EP3043866A4
(en)
|
2013-09-12 |
2017-05-17 |
President and Fellows of Harvard College |
Methods for inducing glucose uptake
|
|
US20160237430A1
(en)
|
2013-09-23 |
2016-08-18 |
President And Fellows Of Harvard College |
Allele-specific rna silencing for the treatment of hypertrophic cardiomyopathy
|
|
EP3060649A4
(en)
|
2013-10-23 |
2017-07-12 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Reprogramming cardiomyocytes with one transcription factor
|
|
WO2015117010A2
(en)
|
2014-01-31 |
2015-08-06 |
Temple University Of The Commonwealth System Of Higher Education |
Bag3 as a target for therapy of heart failure
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
US9287021B2
(en)
*
|
2014-03-04 |
2016-03-15 |
Whirlpool Corporation |
Shelf brackets to conduct electricity to refrigerator shelves
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
TR201818825T4
(tr)
|
2014-04-22 |
2019-01-21 |
Medizinische Hochschule Hannover |
Kardi̇yak hi̇pertrofi̇ni̇n tedavi̇si̇ne ve tanisina yöneli̇k lncrnalar
|
|
WO2016133917A1
(en)
|
2015-02-16 |
2016-08-25 |
University Of Florida Research Foundation |
Raav vector compositions, methods for targeting vascular endothelial cells and use in treatment of type i diabetes
|
|
JP6836999B2
(ja)
|
2015-03-24 |
2021-03-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
アデノ随伴ウイルス変異体及びその使用方法
|
|
WO2016164371A1
(en)
|
2015-04-07 |
2016-10-13 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Methods for inducing cell division of postmitotic cells
|
|
US20180305689A1
(en)
|
2015-04-22 |
2018-10-25 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
EP3337518A4
(en)
|
2015-08-17 |
2019-06-12 |
Temple University Of The Commonwealth System Of Higher Education |
BAG3 COMPOSITIONS AND METHOD
|
|
EP4105321A1
(en)
|
2015-11-01 |
2022-12-21 |
Glycobac, LLC |
Virus-free cell lines and methods for obtaining same
|
|
SG11201803934YA
(en)
|
2015-11-11 |
2018-06-28 |
Intrexon Corp |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
AU2017244205A1
(en)
|
2016-03-30 |
2018-10-25 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Enhanced direct cardiac reprogramming
|
|
KR102598289B1
(ko)
|
2016-04-16 |
2023-11-06 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
바큘로바이러스 시스템-생산된 재조합 아데노-연관 바이러스의 생물학적 효력을 증진시키는 방법
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
US11364308B2
(en)
*
|
2016-05-13 |
2022-06-21 |
4D Molecular Therapeutics Inc. |
Adeno-associated virus variant capsids and methods of use thereof
|
|
WO2017201121A1
(en)
*
|
2016-05-17 |
2017-11-23 |
University Of Florida Research Foundation, Inc. |
Recombinant aav for gene therapy in lungs
|
|
EP3474868A4
(en)
|
2016-06-27 |
2020-07-29 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
MODIFIED GLYCOPROTEINS.
|
|
CN109715218A
(zh)
*
|
2016-07-18 |
2019-05-03 |
嘉安生物治疗有限责任公司 |
用于治疗心脏疾病的组合物和方法
|
|
KR102337932B1
(ko)
|
2016-10-21 |
2021-12-13 |
아지노모토 가부시키가이샤 |
단백질의 분비 생산법
|
|
US10550405B2
(en)
|
2017-03-15 |
2020-02-04 |
The University Of North Carolina At Chapel Hill |
Rational polyploid adeno-associated virus vectors and methods of making and using the same
|
|
WO2018222503A1
(en)
*
|
2017-05-31 |
2018-12-06 |
The Regents Of The University Of California |
Adeno-associated virus with variant capsid and methods of use thereof
|
|
CN107634856B
(zh)
|
2017-09-18 |
2020-12-22 |
金华市智甄通信设备有限公司 |
一种路由器固件升级方法及系统
|
|
ES2976559T3
(es)
|
2017-09-20 |
2024-08-05 |
Univ California |
Terapia génica con conexina 43 para restaurar la función eléctrica y cardíaca y la estructura cardíaca, en la miocardiopatía arritmogénica del ventrículo derecho
|
|
RU2770922C2
(ru)
|
2017-09-20 |
2022-04-25 |
4Д Молекьюлар Терапьютикс Инк. |
Капсиды вариантов аденоассоциированных вирусов и методы их применения
|
|
US12098385B2
(en)
|
2017-09-20 |
2024-09-24 |
The Regents Of The University Of California |
Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy
|
|
EP3774852A1
(en)
|
2018-04-03 |
2021-02-17 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
US20210363193A1
(en)
|
2018-04-27 |
2021-11-25 |
Universität Heidelberg |
Modified aav capsid polypeptides for treatment of muscular diseases
|
|
JP7450945B2
(ja)
|
2018-08-30 |
2024-03-18 |
テナヤ セラピューティクス， インコーポレイテッド |
ミオカルディンおよびａｓｃｌ１を用いた心細胞リプログラミング
|
|
EP3914240A1
(en)
|
2019-01-22 |
2021-12-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Tfap2 inhibition for treating cardiac disease involving fibro-fatty replacement
|
|
AR118493A1
(es)
|
2019-03-28 |
2021-10-20 |
Esteve Pharmaceuticals Sa |
Métodos para la fabricación de vectores virales recombinantes
|
|
EP3947700A4
(en)
|
2019-04-01 |
2023-01-04 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
JP2022530457A
(ja)
|
2019-04-26 |
2022-06-29 |
サンガモ セラピューティクス， インコーポレイテッド |
遺伝子操作ａａｖ
|
|
US20230075314A1
(en)
|
2019-04-29 |
2023-03-09 |
Voyager Therapeutics, Inc. |
VECTORIZED ANTIBODIES (vAb) AND USES THEREOF
|
|
US20220249697A1
(en)
|
2019-05-20 |
2022-08-11 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
|
AU2020299026A1
(en)
|
2019-07-04 |
2022-01-20 |
Children's Medical Research Institute |
Methods and AAV vectors for in vivo transduction
|
|
RU2751592C2
(ru)
|
2019-08-22 |
2021-07-15 |
Общество С Ограниченной Ответственностью "Анабион" |
Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
|
|
EP4022074A4
(en)
|
2019-08-27 |
2023-11-15 |
The Trustees of Columbia University in the City of New York |
Engineered exosomes for targeted delivery
|
|
TWI897882B
(zh)
|
2019-09-20 |
2025-09-21 |
英商Ｕｃｌ商業有限責任公司 |
右心室心律失常性心肌病之基因療法組合物及治療
|
|
CN118221785A
(zh)
|
2019-10-16 |
2024-06-21 |
上海药明康德新药开发有限公司 |
新的aav变体
|
|
WO2021081236A1
(en)
|
2019-10-22 |
2021-04-29 |
Applied Genetic Technologies Corporation |
Triple function adeno-associated virus (aav) vectors for the treatment of c9orf72 associated diseases
|
|
CA3159964A1
(en)
|
2019-12-04 |
2021-06-10 |
Ac Immune Sa |
Novel molecules for therapy and diagnosis
|
|
CN115516100A
(zh)
|
2019-12-20 |
2022-12-23 |
全国儿童医院研究所 |
靶向肌肉疾病中肌肉的优化基因疗法
|
|
US20210284699A1
(en)
|
2020-03-12 |
2021-09-16 |
California Institute Of Technology |
Adeno-associated viral capsids with expanded sizes
|
|
WO2021187380A1
(ja)
|
2020-03-16 |
2021-09-23 |
国立大学法人大阪大学 |
不整脈源性心筋症患者由来の多能性幹細胞およびその利用ならびに不整脈源性心筋症治療用医薬
|
|
EP4192580A4
(en)
|
2020-08-05 |
2025-06-18 |
AskBio Inc. |
Methods for treating heart disease and congestive heart failure and administration of AAV vectors
|
|
KR20230043869A
(ko)
|
2020-08-07 |
2023-03-31 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
|
|
EP3957650A1
(en)
|
2020-08-17 |
2022-02-23 |
Themis Bioscience GmbH |
Co-stimulatory 4-1bbl ectodomain polypeptides for immunomodulation
|
|
US20240082389A1
(en)
|
2020-09-23 |
2024-03-14 |
Lonza Sales Ag |
Methods of producing extracellular vesicles
|
|
IL301255A
(en)
|
2020-10-09 |
2023-05-01 |
UCB Biopharma SRL |
Nucleic acid structures, viral vectors and viral particles
|
|
BR112023006305A2
(pt)
|
2020-10-09 |
2023-05-09 |
Tenaya Therapeutics Inc |
Métodos e composições de terapia gênica com placofilina-2
|
|
US11781156B2
(en)
|
2020-10-09 |
2023-10-10 |
Tenaya Therapeutics, Inc. |
Plakophillin-2 gene therapy methods and compositions
|
|
EP4229204A1
(en)
|
2020-10-15 |
2023-08-23 |
F. Hoffmann-La Roche AG |
Nucleic acid constructs for simultaneous gene activation
|
|
US20240026381A1
(en)
|
2020-11-03 |
2024-01-25 |
The Board Of Trustees Of The University Of Illinois |
Split prime editing platforms
|
|
TW202237850A
(zh)
|
2020-12-01 |
2022-10-01 |
賓州大學委員會 |
具有組織特異性靶向基序的新穎構成物及含有其之組成物
|
|
WO2022119974A1
(en)
|
2020-12-01 |
2022-06-09 |
Locanabio, Inc. |
Rna-targeting compositions and methods for treating cag repeat diseases
|
|
JP2023551874A
(ja)
|
2020-12-01 |
2023-12-13 |
ロックアネイビオ， インコーポレイテッド |
筋強直性ジストロフィー１型を処置するためのｒｎａ標的化組成物および方法
|
|
US20240115734A1
(en)
|
2021-02-09 |
2024-04-11 |
Affinia Therapeutics Inc. |
Recombinant aavs with improved tropism and specificity
|
|
AU2022239846A1
(en)
|
2021-03-19 |
2023-10-26 |
Ucl Business Ltd |
Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathy
|
|
CA3212612A1
(en)
|
2021-03-26 |
2022-09-29 |
Brent E. STEAD |
Targeting oncogentic mutations with dual-cleaving endonuclease
|
|
US20240173355A1
(en)
|
2021-04-05 |
2024-05-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene correction for rag2 deficiency in human stem cells
|
|
WO2022216574A1
(en)
|
2021-04-05 |
2022-10-13 |
Janssen Biotech, Inc. |
Calr and jak2 t-cell receptors
|
|
CA3216004A1
(en)
|
2021-04-23 |
2022-10-27 |
The Trustees Of The University Of Pennsylvania |
Novel compositions with brain-specific targeting motifs and compositions containing same
|
|
JP2025512405A
(ja)
|
2022-04-11 |
2025-04-17 |
テナヤ セラピューティクス， インコーポレイテッド |
プラコフィリン２遺伝子治療の処置の方法
|
|
AR129033A1
(es)
|
2022-04-11 |
2024-07-10 |
Tenaya Therapeutics Inc |
Cápsides para terapia con el gen de placofilina-2
|